Wilmington resident joins motorcycle ride Jul 2, 2009
It is a leader in the discovery, development, manufacturing and marketing of pharmaceuticals, vaccines, biotechnology products, nutritionals and non-prescription medicines that improve the quality of life for people worldwide. The company s major divisions include Wyeth Pharmaceuticals, Wyeth Consumer Healthcare and Fort Dodge Animal Health. (Wilmington Advocate, MA)
Researchers testing virus-gene therapy combination against melanoma Jul 2, 2009
OncoVEX GM-CSF is made by BioVex, a Woburn, MA-based biotechnology company. For more information about this trial, please contact Trang Tran, clinical trials coordinator, at 858-822-4171 or. (EurekAlert!)
Tri-Town turns down $250K offer Jul 2, 2009
LNR s blueprint additionally includes a hotel, an 18-hole golf course, a conference center, boutique shops, restaurants, hiking baths, walkways, recreational fields, and a two million square foot commercial complex to accommodate a pharmaceutical company or biotechnology firm. The timeline for constructing these amenities is being pushed back because of the slow economy and the difficulties Tri-Town is having obtaining bonds. (Weymouth News, MA)
GSK deal to provide China with flu vaccines Jul 2, 2009
LONDON (AFP) Pharmaceutical giant GlaxoSmithKline has said it had sealed a joint venture with Chinese biotechnology group Shenzhen Neptunus focused on making flu vaccines for China and neighbouring territories. "The alliance will develop and manufacture influenza vaccines for China, Hong Kong and Macau," GSK said in a statement on Tuesday. (Yahoo News -- Pharmaceutical Industry News)
AT&T adds Fresno-area wireless spectrum Jul 2, 2009
Spectrum Pharmaceuticals, Inc. (NasdaqGM:SPPI), a commercial-stage biotechnology company with two proprietary, FDA-approved oncology drugs on the market, today announced that it has received $10 million from two existing institutional investors in a previously announced registered direct offering ... Spectrum Pharmaceuticals (NasdaqGM:SPPI), a commercial-stage biotechnology company with a focus in oncology, today announced that Russell Investments has added Spectrum Pharmaceuticals to the... (Fresno Bee)
Patent Attorney Wins Historic National Women's Air Race Classic Jul 2, 2009
Brinks routinely handles assignments in fields as diverse as electrical, chemical, mechanical, biotechnology, pharmaceutical, nanotechnology, Internet and computer technology, as well as in trademarks and brand names for a wide variety of products and services. For more information, visit. (PR Newswire)
Turning research into a tool for economic growth in Kannapolis Jul 2, 2009
In that role, the veteran of the pharmaceutical and biotechnology industry is mapping out a strategy for the institute s research into health, nutrition and agriculture. The Kannapolis institute, with about 23 full-time staffers, supports efforts at the 350-acre life-sciences hub, including the 311,000-square-foot David H. Murdock Core Laboratory. (Charlotte Business Journal, NC)
New e-science service could accelerate cancer research Jul 2, 2009
The project is been funded by the Biotechnology and Biological Sciences Research Council (BBSRC). . (EurekAlert! -- Business News)
ASU seeks to be green-energy powerhouse Jul 2, 2009
The researchers at the Laboratory for Algae Research and Biotechnology study not only fuel but also how to use algae's byproducts as animal feed and nutritional supplements, including vitamins B, C, D and E. ... "Our goal is to bring the price (of biodiesel from algae) down from $20 a gallon (today) to $2 a gallon in the next three years," said Qiang Hu, who runs the Laboratory for Algae Research and Biotechnology with Sommerfeld ... Victoria Balogh, a biological-science major, checks algae... (AZCentral -- Business)
Neurocrine shares plunge on FDA rejection Jul 2, 2009
Shares in plummeted to their lowest level in more than five years, illustrating the peril faced by small companies -- including dozens of Boston area biotechnology firms -- whose value rests on a single product that has not yet reached the market. The FDA turned down an application by the 14-year-old San Diego company and , the world's largest drug maker, to sell a 15 milligram extended-release version of the insomnia drug Indiplon. (Yahoo News -- Sleep and Sleep Disorders)
Sepracor tumbles as drugs suffer setback Jul 2, 2009
biotechnology company, yesterday suffered a double setback as its experimental depression drug failed a midstage study and US regulators halted two pediatric studies of its blockbuster Lunesta insomnia pill, sending shares down over 15 percent in after-hours trading. The firm said its experimental depression medicine, SEP-225289, failed to reduce symptoms of depression following eight weeks of treatment in a phase 2 study involving 514 patients. (Boston Globe)
3D Entertainment Summit Unveils New Partnership with Variety and Announces Entertainment Technology Center at USC as Presenting Partner Jul 1, 2009
In addition, Unicomm has developed leading events in the biotechnology, research opment and mechanical engineering, human resources, transportation and other markets. The companys "value-added" resources are the intellectual capital of its people and proprietary business practices. (Yahoo! Wire -- Entertainment News)
NYPD: High-profile buildings need tighter security Jul 1, 2009
The facility was built for, and is fully leased to, Illumina, Inc., one of San Diego's largest biotechnology companies, which is focused on developing, manufacturing and marketing next-generation tools for the large-scale analysis of genetic variation and biological function. Illumina leases a total of approximately 193,000 square feet through October 2023 at the Towne Centre Drive campus in San Diego. (Fresno Bee -- Nation)
Amag wins FDA approval for Feraheme Jul 1, 2009
Eric Varma, biotechnology analyst for Leerink Swann LLC, a healthcare investment bank in Boston, projected Feraheme will reach annual sales of $300 million by 2013. Whether sales can grow further to reach the company s goal of $1 billion a year will partly depend on whether it gains off-label approval to treat other classes of patients with chemotherapy-induced anemia and postpartum anemia, Varma said. (Boston Globe)
Dr. Orrie M. Friedman, 94, biotech pioneer Jul 1, 2009
Dr. Friedman, who founded Collaborative Research Inc., which helped pioneer the field of biotechnology, then used his riches for philanthropy, died in his Brookline home Sunday of complications from Parkinson s disease ... In 1961, he left Brandeis to start Collaborative Research in the nascent days of an industry not yet called biotechnology ... He also set an example of how to keep a vibrant life outside the laboratory, skiing into his mid-80s and then picking up the brush to create painting... (Boston Globe)
Tewksbury students honored at WPI Jul 1, 2009
Tommy Tashjian, of Tewksbury, is a senior majoring in Biology and Biotechnology Steven Southard, of Tewsbury, is a sophomore majoring in Mechanical Engineering Gregory Lobdell, of Tewksbury, is a sophomore majoring in Biochemistry Scott Steinmetz, of Wilmington, is a senior majoring in Electrical and Computer Engineering Evan Guarino, of Wilmington, is a junior majoring in Civil Engineering ... WPI s world-class faculty work with students in a number of cutting-edge research areas, leading to... (Tewksbury Advocate, MA)
Scientists Kill Cancer Cells with "Trojan Horse" Jul 1, 2009
The therapy, published in the latest Nature Biotechnology journal, sees mini-cells called EDVs (EnGenelC Delivery Vehicle) attach and enter the cancer cell ... RNA interference, or RNAi, is designed to silence genes responsible for producing disease-causing proteins and is one of the hottest areas of biotechnology research ... Dozens of biotechnology companies are looking for ways to manipulate RNA to block genes that produce disease-causing proteins involved in cancer, blindness or AIDS.. (MEDLINEplus)
Watson to go global with $1.75 billion Arrow buy Jul 1, 2009
The deal also may provide Watson a foundation in the burgeoning market for generic biotechnology drugs, as Arrow owns 36 percent of Eden Biodesign, which provides services to early-stage biotechnology companies. Arrow, which sells more than 100 products, expects approval of 40 more over the next three years. (Yahoo News -- Pharmaceutical Industry News)
Area GOP legislators disappointed in plan Jul 1, 2009
2 million on biotechnology, nanotechnology and information technologies research at the Wisconsin Institutes for Discovery, a research institute at the University of Wisconsin-Madison and over 240 million over six years at the University of Wisconsin-Milwaukee to expand its research and economic development activities. The governor and members of the Legislature deserve credit for continuing to invest in Wisconsin's knowledge-based economy, even during a budget year that required tough... (Watertown Daily Times, WI)
Biogen shares drop on 10th Tysabri PML case Jun 30, 2009
Shares of sank Monday after the biotechnology giant confirmed that another patient taking the multiple sclerosis drug Tysabri has been diagnosed with a potentially fatal brain infection called progressive multifocal leukoencephalopathy, or PML.. The patient, who lives overseas and had been taking Tysabri for more than 30 months, is the 10th person to come down with PML since the multiple sclerosis drug was allowed back onto pharmacy shelves in 2006. (Triangle Business Journal)
BioMed Realty Trust Completes $350 Million Financing for Center for Life Science | Boston Jun 30, 2009
The company's tenants primarily include biotechnology and pharmaceutical companies, scientific research institutions, government agencies and other entities involved in the life science industry. BioMed Realty Trust owns or has interests in 69 properties, representing 112 buildings with approximately 10. (PR Newswire)
SIUE goes to court over failed hotel Jun 30, 2009
University Park currently has 23 tenants representing a number of business sectors including agricultural biotechnology, health sciences, design professionals and information technology. The most recent announced addition to the park is the Blood Processing Center and National Testing Laboratory. (St. Louis Business Journal, MO)
UMBI names Eisenstein interim president Jun 30, 2009
University of Maryland Biotechnology Institute names Edward Eisenstein acting president - Baltimore Business Journal ... University of Maryland Biotechnology Institute names Edward Eisenstein acting president ... The director of one of UMBI s four research centers, the Center for Advanced Research in Biotechnology in Rockville, Eisenstein will work with USM Chancellor William E. Brit Kirwan and other USM officials as UMBI gets broken up. (Baltimore Business Journal, MD)
Genentech-Roche to Pull Out of PhRMA Jun 30, 2009
According to the statement, the newly combined company will work through the Biotechnology Industry Organization of which Genentech was already a member ... Moving forward, Genentech will continue to focus on working with BIO, the trade association and voice for the biotechnology industry, Wilson s statement said ... As part of the world s largest biotechnology company, Genentech and Roche believe that BIO s purpose is closely aligned with the direction of the new company and, therefore, can... (Roll Call)
High school students gets hands-on experience at biotech camp Jun 30, 2009
From left, Columbia Central High School students Joel Morrison and Amanda Gish work together on an experiment at Columbia State Community College s Biotechnology Summer Camp. The camp gave students the opportunity to increase their knowledge of biotechnology through hands-on laboratory experiments. (Columbia Daily Herald, TN)
What Brain Researchers Forgot Jun 30, 2009
In South San Francisco biotechnology firm Izumi Bio is taking skin cells from patients with a familial form of als, then using cellular reprogramming methods to turn them into neurons, glia and other brain cells. The aim is to create what Izumi scientists call a "disease in a dish" and screen potential drugs against it. (Forbes -- Technology)
Govt to check dumping of biotech products Jun 30, 2009
AS the debate on the use of biotechnology for better agricultural yields and the much-sought food security for Nigeria ranges on, the Federal Government says it would not allow the country to be made a dumping ground for hybrid products. Minister of Environment, Mr. John Odey, declared this yesterday at the Open Forum on Agriculture Biotechnology in Africa (OFAB) organised by the National Biotechnology Development Agency (NABDA) in Abuja ... Represented at the event by the Head of BioSafety Desk... (Guardian News, Nigeria)
'Trojan Horse' Therapy Kills Cancer Cells Jun 30, 2009
The research, outlined in the journal Nature Biotechnology, has the potential to reduce the side effects of cancer treatment and make it cheaper, said Himanshu Brahmbhatt from Sydney-based biotechnology company EnGeneIC.. The technology allowed medics to target cancer cells without damaging healthy tissue, a major problem with existing chemotherapy treatments, Brahmbhatt said. (Newsmax)
Facebook names new chief financial officer Jun 30, 2009
David Ebersman, the former executive vice president and CFO of Genentech, the biotechnology firm recently acquired by Roche, will take over as CFO of Facebook from September, the Palo Alto, Calfornia-based Facebook said. Ebersman will report to Facebook chief executive and founder Mark Zuckerberg and will oversee the company's finance, accounting, investor relations, and real estate functions, Facebook said in a statement. (Yahoo! Asia News)
Crop plants get genomics centre Jun 30, 2009
Britain's biotechnology research council the BBSRC will this week open a research centre to decode the DNA of plants and animals used in agriculture. Among its aims is to help farmers boost food production. (BBC News -- Science)
Gillings lab at UNC wins $8.5M contract Jun 30, 2009
CROs run clinical trials on drug candidates for pharmaceutical and biotechnology companies. Reader Comments. (Triangle Business Journal)
Five-step check for nano safety Jun 30, 2009
The group of experts says that if the global research community can take advantage of the safety infrastructure already in place for biotechnology and computing, then nanotechnology has a rosy future. But Dr Maynard, from the Woodrow Wilson International Center for Scholars in Washington DC, and colleagues say that the way science is carried out means it is ill-equipped to address novel risks from emerging technologies. (Yahoo News -- Nanotechnology)
Drug deals cost U.S. consumers $3.5 bln a year: FTC Jun 30, 2009
The FTC has calculated that consumers could save even more if generic companies were allowed to make copies of expensive biotechnology drugs, something the U.S. Food and Drug Administration does not now allow. (Reporting by Julie Vorman and Diane Bartz; editing by John Wallace). (Yahoo News -- Pharmaceutical Industry News)
* FEATURE : CTX expands into lithium-iron batteries, LED lamps Jun 29, 2009
CTX partnered with Taichung-based Jing Wang Biotechnology Co (), in which Chen has personal investments, two years ago to launch its beauty product line, which features pearl peptide and ginseng extracts to organically fight aging and all sorts of skin problem. Built mostly on word of mouth, sales of the equally profitable beauty line have grown, defying the recent economic downturn, to account for 20 percent of the companys total revenues last year. (Taipei Times, Taiwan -- Sports)
Wockhardt, Biocon under scanner Jun 29, 2009
The Mumbai-based pharmaceutical and biotechnology major Wockhardt had launched Glaritus in February this year ... Biotechnology major Biocons product Basalog was launched in May 2009. (India Times)
Novartis in Talks to Buy Much of Elan: Report Jun 29, 2009
It said on June 10 it expected to conclude a strategic transaction "in the near term", after talking over the past few months with a number of the global players in pharmaceuticals and biotechnology. Chief Executive Kelly Martin then declined, however, to comment on whether discussions had broken down with Bristol-Myers Squibb Co , as a source had earlier told Reuters. (ABC News -- Wire)
WuXi PharmaTech Named a Top Ten Chinese Outsourcing Enterprise Jun 29, 2009
WuXi PharmaTech is a leading pharmaceutical, biotechnology, and medical device R&D outsourcing company, with operations in China and the United States. As a research-driven and customer-focused company, we provide a broad and integrated portfolio of laboratory and manufacturing services throughout the drug and medical device R&D process. (PR Newswire)
Evotec Announces the Successful Completion of the First Phase I Study With EVT 401, An Oral P2X7 Receptor Antagonist -- Very Good Safety Profile and Confirmed 'On Target Activity' Jun 29, 2009
Leveraging these skills and expertise the Company intends to develop best-in-class differentiated therapeutics and deliver superior science-driven discovery alliances with pharmaceutical and biotechnology companies. Evotec has long-term discovery alliances with partners including Boehringer Ingelheim, CHDI, Novartis, Ono Pharmaceutical and Roche. (Primezone Releases)
Marcial: Achillion, a Promising Biotech Jun 29, 2009
Investors scouting for depressed stocks that could spring positive surprises are turning to the biotechnology sector, which didn't significantly participate in the market's frenzied three-month rally. Analysts note that what's being pursued are biotech companies with compounds that show promise to become compelling drugs and whose stocks are still at depressed levels. (BusinessWeek)
Biotech Generic-Drug Makers Win a Round Jun 29, 2009
If a health-care reform package makes it through Congress this year, it's safe to assume it will include a defined regulatory pathway for generic biotechnology drugs. But there's one major question for which generic and brand-name drugmakers can't find a mutually agreeable answer: How long should a biotech company own the data that reveal how it created a drug. (BusinessWeek)
Gene Therapy Gets Under The Skin Jun 29, 2009
Marc Gitzinger from the research group of Martin Fussenegger, Professor of Biotechnology and Bioengineering Science in the Department of Biosystems (D-BSSE) in Basle, has developed a prototype for gene therapy through the skin. An important part in this is played by phloretin, an antioxidant found in apples which makes cell walls more permeable and is used in cosmetics as an anti-wrinkle agent. (Science Daily)
The following is an investment opinion release issued by Pennystockchaser.com Jun 28, 2009
62 Sector: Healthcare, Industry: Biotechnology products deCODE Genetics (NASDAQ:) up 50% trading at $0. 45 Sector: Healthcare, Industry: Biotechnology Yadkin Valley Financial Corp (NASDAQ:) up 40% trading at $7. (PR Newswire)
Local biotechs search for partners to help them survive Jun 28, 2009
At one of the omnipresent coffee shops in downtown Chicago, walking distance from the bustle of the Biotechnology Industry Organization s 14th annual convention, representatives from two companies chatted about a peptide-boosting, diabetes-defeating monoclonal antibody over recycled cups of java. With that, a relationship began to brew between biotech up-and-comer and pharmaceutical gargantuan Eli Lilly & Co.. (Washington Business Journal, DC)
Michael Jackson Get the Medical Facts Behind the Headlines at CelebrityDiagnosis.com Jun 28, 2009
Dr. Boguski has held positions at the U.S. National Institutes of Health, the U.S. National Library of Medicine and in the biotechnology and pharmaceutical industries. He is a former vice president of Novartis and was honored as a Visionary and Influencer by the Personalized Medicine Coalition in 2006. (Yahoo News -- Press Releases)
Laid-off workers, local experts look at area job trends Jun 28, 2009
A study under way on industry opportunities in the region has singled out advanced manufacturing, health care, agriculture/food processing, professional and business services, and the emerging sectors of biotechnology and renewable energy, Hanoski said. More News. (La Crosse Tribune, WI)
Biotechnology Can Reduce Carbon Footprint of a Gallon of Milk (1) Jun 28, 2009
Biotechnology Can Reduce Carbon Footprint of a Gallon of Milk Agri-View: Dairy News ... Biotechnology Can Reduce Carbon Footprint of a Gallon of Milk ... Last week at the World Dairy Expo, dairy farmers - often overlooked as environmentalists - learned how biotechnology is maximizing their focus on resource conservation and making the dairy industry even greener. (Agri-View, WI)
Innovation called vital for biotech to survive Jun 27, 2009
Neal Gutterson, chief executive of Mendel Biotechnology of Hayward, attended the summit to talk about efforts to develop grasses into fuels that would release about the same amount of carbon when burned as they absorbed from the atmosphere while growing. "We could start burning within three years," he said. (San Francisco Chronicle)
Johns Hopkins event aims to match biotech research with business acumen Jun 27, 2009
The goal is to ultimately spin out more companies founded on Johns Hopkins research that will take up space in the emerging East Baltimore biotechnology park, said Michael S. Rose, senior vice president of commercial developer , the biopark's developer. Johns Hopkins hopes to create companies that produce drugs, medical evaluations and diagnostic tools. (Washington Business Journal, DC)
Kurtz hopes Windber Research Institute will be his last stop Jun 27, 2009
A partner with Pivotal Technology Group in Johnstown, Kurtz was named the new president and CEO of Windber Research Institute. The institute and Windber Medical Center were clients of his in his previous job, along with the U.S. Department of Veterans Affairs and the Pennsylvania Senate. (Somerset Daily American, PA)
Wide World of Stocks Debuts to Showcase Microcap Equities Jun 27, 2009
The first company to be featured will be Viral Genetics, Inc. (VRAL.PK), a biotechnology company that develops drug compounds for auto-immune diseases. The program is in the final stages of legal department approval at three major networks and two cable channels and is expected to be accessible to over 95 million homes nationwide. (Yahoo! Wire -- Entertainment News)
UK 'space jewel' set for polish Jun 27, 2009
" This is just the latest IGT established by government. Previous panels have been set up to examine the potential for wealth creation in areas such as biotechnology and the auto industry. The Space IGT is expected to come forward with some preliminary findings by the end of the year, and then deliver its full report in early 2010. Esa investmentLord Drayson already has a report on his desk detailing how the UK can play its part in the changing goals of space exploration. Soon, he is also likely... (BBC News -- Science)
Virus Filters For Medical Diagnosis Jun 27, 2009
ScienceDaily (June 26, 2009) In biomedicine and biotechnology the smallest, complex, compound sample quantities must be reliably processed ... 5, 2005) Scientists from the Flanders Interuniversity Institute for Biotechnology (VIB) have again achieved a breakthrough in research on hepatitis. (Science Daily)
Roaming rabbi finds a new home Jun 27, 2009
After graduating, she worked as a research assistant and in sales and marketing for a biotechnology company nine years before deciding on rabbinical school. In 1991, she entered Hebrew Union College-Jewish Institute of Religion. (The Clarion-Ledger)
State's Good Government Agency Calls for Reforms at Stem Cell Agency Jun 27, 2009
Five would be patient advocates; two would come from the University of California; one from a non-UC university; two from biotechnology companies and one from a California research institution. It would simply call the oversight body the Board of Directors. (PR Newswire)
Genzyme drugs could be rationed for longer Jun 26, 2009
The extension is a result of an expanded cleanup effort at the biotechnology company s Boston manufacturing plant and lower inventory for one of the drugs than initially calculated ... Citing the longer sales interruption, Mark Schoenebaum, senior biotechnology analyst at , yesterday boosted his forecast of Genzyme s revenue shortfall stemming from the virus to $245 million, up from an earlier forecast of $100 million. (Boston Globe)
Watson to go global with $1.75 billion Arrow buy Jun 26, 2009
The deal also may provide Watson a foundation in the burgeoning market for generic biotechnology drugs, as Arrow owns 36 percent of Eden Biodesign, which provides services to early-stage biotechnology companies. Arrow, which sells more than 100 products, expects approval of 40 more over the next three years. (Yahoo News -- Pharmaceutical Industry News)
Drug deals cost U.S. consumers $3.5 bln a year: FTC Jun 26, 2009
The FTC has calculated that consumers could save even more if generic companies were allowed to make copies of expensive biotechnology drugs, something the U.S. Food and Drug Administration does not now allow. (Reporting by Julie Vorman and Diane Bartz; editing by John Wallace). (Yahoo News -- Pharmaceutical Industry News)
GSK deal to provide China with flu vaccines Jun 26, 2009
LONDON (AFP) Pharmaceutical giant GlaxoSmithKline has said it had sealed a joint venture with Chinese biotechnology group Shenzhen Neptunus focused on making flu vaccines for China and neighbouring territories. "The alliance will develop and manufacture influenza vaccines for China, Hong Kong and Macau," GSK said in a statement on Tuesday. (Yahoo News -- Pharmaceutical Industry News)
Diabetes is significant economic burden for US health-care system Jun 26, 2009
Its biotechnology trade magazine, Genetic Engineering chnology News (GEN), was the first in its field and is today the industry's most widely read publication worldwide. A complete list of the firm's 60 journals, books, and newsmagazines is available at. (EurekAlert!)
Akebia names Howes CFO Jun 26, 2009
a biotechnology company focused on anemia and vascular disorders, has appointed Ian Howes as its chief financial officer. Howes, who also will serve as vice president for corporate development, joins Akebia from Serenex. (Cincinnati Business Courier, OH)
Neurocrine shares plunge on FDA rejection Jun 26, 2009
Shares in plummeted to their lowest level in more than five years, illustrating the peril faced by small companies -- including dozens of Boston area biotechnology firms -- whose value rests on a single product that has not yet reached the market. The FDA turned down an application by the 14-year-old San Diego company and , the world's largest drug maker, to sell a 15 milligram extended-release version of the insomnia drug Indiplon. (Yahoo News -- Sleep and Sleep Disorders)
European researchers look for new ways to fight multi-drug-resistant bacterial infections Jun 26, 2009
The UAB Institute of Biotechnology and Biomedicine to direct the AntiPathoGN project. The Institute of Biotechnology and Biomedicine (IBB) belonging to Universitat Autnoma de Barcelona (UAB) is directing the AntiPathoGN European research project aimed at looking for new drug targets in pathogenic bacteria resistant to multiple antibiotics ... Other participating institutes are the Institute for Biomedical Research (IRB Barcelona), the Clinical Foundation for Biomedical Research (Fundaci Clnic... (EurekAlert! -- Business News)
Mouse cloned to cure Parkinson's Jun 26, 2009
The embryonic "stem cells", reports the journal Nature Biotechnology, were grown into new tissue which was implanted into the mouse brain. However, many obstacles stand in the way of human treatments, say experts. (Yahoo News -- Parkinson's Disease)
Whyte Hirschboeck CEO to leave firm Jun 26, 2009
The law firm's board praised Miller s leadership, saying under his direction the firm experienced significant growth and added new practice areas including public finance, state and local taxation, post-secondary education and biotechnology. Miller will aid in the transition to a new CEO, said Bruce Arnold, one of the firm s managing directors. (Milwaukee Business Journal, WI)
Elliott's hedged maneuver Jun 26, 2009
Napodano says he is not surprised by the hedge fund activity around BioDelivery s stock, which often happens with biotechnology stocks. The rising stock price offers the opportunity to make a lot of money, but the chance of not getting FDA approval also means there s risk. (Raleigh Triangle Business Journal, NC)
